← Back to Search

Procedure

Open Partial Nephrectomy for Kidney Tumors (CONVERT Trial)

N/A

Waitlist Available

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up study duration (2 years)

Awards & highlights

CONVERT Trial Summary

This trial is testing whether robotic partial nephrectomy is a feasible option for patients with T1 renal masses.

CONVERT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ study duration (2 years)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~study duration (2 years)

This trial's timeline: 3 weeks for screening, Varies for treatment, and study duration (2 years) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Recruitment Potential

Resource Utilization - Cost of Study Participation

Resource Utilization - Operating Room/Robotic Studio Time Availability

+1 more

Secondary outcome measures

Analgesic Requirements

Blood Loss

Complication Rates

+10 more

CONVERT Trial Design

2Treatment groups

Active Control

Group I: Open Partial NephrectomyActive Control1 Intervention

Partial nephrectomy performed using the open approach.

Group II: Robotic Partial NephrectomyActive Control1 Intervention

Partial nephrectomy performed using the DaVinci robotic surgical system.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor

1,468 Previous Clinical Trials

484,490 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the ultimate goal of this research endeavor?

"This two-year clinical trial is primarily focused on patient recruitment potential. Secondary objectives include monitoring the length of hospital stay, warm ischemia time (calculated in minutes from clamping to unclamping a vessel), and conversion rate between robotic partial nephrectomy and radical nephrectomy (measured by time taken for decision making)."

Answered by AI

Is this medical research actively seeking participants?

"As of now, this clinical trial is open for applicants. It was initially announced on November 1st 2019 and the particulars were recently updated on April 13th 2022."

Answered by AI

What is the size of the cohort enrolled in this medical trial?

"Affirmative. Documentation found on clinicaltrials.gov displays that this investigation is actively looking for test subjects; the trial was first posted in November 2019 and its information has been renewed as of April 13th 2022. To accomplish their goals, they need to recruit 30 individuals from a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Comparison of OpeN VErsus RoboTic Partial Nephrectomy

2019. "Comparison of OpeN VErsus RoboTic Partial Nephrectomy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04011891.